Professional Documents
Culture Documents
If you have any further questions on the use of this medicine, ask your This medicinal product is authorised in the Member States of the EEA
doctor or pharmacist. under the following names:
4. Possible side effects Austria Dymista Nasenspray Latvia Dymista 137
Like all medicines Dymista can cause side effects, although not everybody mikrogrami/50
gets them. mikrogrami devā
Very common side effects (These may affect more than 1 in 10 deguna aerosols,
people): suspensija
• Nosebleed
Liechtenstein Dymista
Common side effects (These may affect up to 1 in 10 people): Nasenspray
• Headache Bulgaria Dymista Lithuania Dymista 137
• A bitter taste in your mouth, especially if you tilt your head backwards mikrogramai/50
when you are using the nasal spray. This should go away if you have a mikrogramų /
soft drink a few minutes after using this medicine. dozėje nosies
• Unpleasant smell purškalas
(suspensija)
Uncommon side effects (These may affect up to 1 in 100 people):
• Slight irritation of the inside of the nose. This can cause mild stinging, Cyprus Dymista Ρινικό Luxembourg Dymista
itching or sneezing. εκνέφωμα Neusspray /
• Nasal dryness, cough, dry throat or throat irritation Suspension pour
Rare side effects (These may affect up to 1 in 1,000 people): pulvérisation
nasale /
• Dry mouth
Nasenspray
Very rare side effects (These may affect up to 1 in 10,000 people):
• Dizziness or drowsiness Czech Dymistin 137 Malta Dymista Nasal
• Cataract, glaucoma or increased pressure in your eye where you may Republic mikrogramů / Spray
have a loss of vision and/or red and painful eyes. These side effects 50 mikrogramů, nosní
have been reported following prolonged treatment with fluticasone sprej, suspenze
propionate nasal sprays.
• Damage of the skin and mucous membrane in the nose
• Feeling sick, weary, exhausted or weak Denmark Dymista
• Rash, itchy skin or red, raised itchy bumps Estonia Dymista Norway Dymista nesespray
• Bronchospasm (the narrowing of the airways in the lungs) Finland Dymista nenäsumute Poland Dymista
France Dymistalin Portugal Dymista Spray
Seek immediate medical help if you have any of the following Suspension pour nasal
symptoms: pulvérisation nasale
• Swelling of face, lips, tongue or throat which may cause difficulty Germany Dymista Nasenspray Romania Dymista 137
in swallowing/breathing and a sudden onset of skin rash. This 137 Mikrogramm/50 micrograme / 50
could be signs of a severe allergic reaction. Please note: This is Mikrogramm pro micrograme /doza
very rare. Sprühstoß spray nazal
Side effects with unknown frequency (frequency cannot be estimated Nasenspray, suspensie
from available data): Suspension
• Blurred vision Greece Dymista Ρινικό Slovak Dymista nosová
εκνέφωμα Republic aerodisperzia
• Sores in the nose
Hungary Dymista Slovenia Dymista 137
Systemic side effects (side effects concerning the whole body) may occur Szuszpenziós mikrogramov / 50
when this medicine is used at high doses for a long time. These effects are orrspray mikrogramov na
much less likely to occur if you use a corticosteroid nasal spray than if you vpih pršilo za nos,
take corticosteroids by mouth. These effects may vary in individual patients suspenzija
and between different corticosteroid preparations (see section 2). Iceland Dymista Nefúði Spain Dymista
Nasal corticosteroids can affect the normal production of hormones in your suspensión
body, particularly if you use high doses for a long time. In children and pulverización nasal
adolescents this side effect can cause them to grow more slowly than Ireland Dymista, 137 Sweden Dymista Nässpray,
others. micrograms/50 suspension
In rare cases a reduction of the bone density (osteoporosis) was observed, micrograms per (1mg/g; 0.365
if nasal corticosteroids were administered long-term. actuation Nasal mg/g)
Spray, Suspension
Reporting of side effects
Italy Dymista United Dymista Nasal
If you get any side effects, talk to your doctor, pharmacist or nurse. This
Kingdom Spray
includes any possible side effects not listed in this leaflet. You can also
report side effects directly via HPRA Pharmacovigilance, Earlsfort Terrace,
IRL - Dublin 2; Tel: +353 1 6764971; Fax: +353 1 6762517.
This leaflet was last revised in July 2020
Website: www.hpra.ie; E-mail: medsafety@hpra.ie.
By reporting side effects you can help provide more information on the
Dymista is a registered trademark of Meda AB, Sweden.
safety of this medicine.
5. How to store Dymista
Keep this medicine out of the sight and reach of children. Blind or partially sighted?
Do not use this medicine after the expiry date which is stated on the bottle
label and the outer carton after “EXP”. The expiry date refers to the last Is this leaflet hard to see or read?
day of that month.
Do not refrigerate or freeze. Phone Merit Pharmaceuticals Ltd,
Shelf life after first opening: Dispose of any unused medicine 6 months
after you first open the nasal spray. Tel: 01 8131010 to obtain the leaflet in
Do not throw away any medicines via wastewater or household waste. Ask
your pharmacist how to throw away medicines you no longer use. These a format suitable for you.
measures will help protect the environment.
6. Contents of the pack and other information
What Dymista contains
The active substances are: azelastine hydrochloride and fluticasone
propionate.
Each g of suspension contains 1000 micrograms azelastine hydrochloride
and 365 micrograms fluticasone propionate.
Each actuation (0.14 g) delivers 137 micrograms azelastine hydrochloride
(= 125 micrograms azelastine) and 50 micrograms fluticasone propionate.
The other ingredients are: Disodium edetate, glycerol, microcrystalline
cellulose, carmellose sodium, polysorbate 80, benzalkonium chloride
solution, phenylethyl alcohol and purified water.